A dynamic network of startups coming out of McMaster University — along with an eye- popping takeover of a homegrown success story — is fuelling Hamilton’s rise as a national biotech capital.
McMaster SynBio, a student-led research team, has received an award for their work on a biological therapy project targeting inflammatory bowel disease (IBD).
Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening the way for life-saving anti-viral vaccines to reach remote and impoverished regions of the world.